Literature DB >> 7860071

A recombination event excludes the ROM1 locus from the Best's vitelliform macular dystrophy region.

H Stöhr1, B H Weber.   

Abstract

Best's vitelliform macular degeneration has been genetically linked to chromosome 11. Subsequently, the disease locus has been refined to an interval between D11S903 and PYGM and, more recently, between D11S986 and D11S480. The gene encoding ROM1, a photoreceptor-specific membrane protein, has been independently mapped within the Best's disease region and has thus become a strong candidate for the Best's disease gene. In this study, we have mapped ROM1 relative to Best's disease and the loci D11S986, UGB (uteroglobin), and PYGM (human muscle glycogen phosphorylase) in recombinant Best's disease chromosomes. We demonstrate that UGB is localized proximal to ROM1 and that both UGB and ROM1 recombine with the disease phenotype. Thus, this analysis excluded ROM1 as the Best's disease gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860071     DOI: 10.1007/bf00209406

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Best's vitelliform dystrophy (VMD2) maps between D11S903 and PYGM: no evidence for locus heterogeneity.

Authors:  B H Weber; D Walker; B Müller; L Mar
Journal:  Genomics       Date:  1994-03-15       Impact factor: 5.736

3.  High-resolution meiotic and physical mapping of the best vitelliform macular dystrophy (VMD2) locus to pericentromeric chromosome 11.

Authors:  B H Weber; G Vogt; H Stöhr; S Sander; D Walker; C Jones
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

4.  Fast and slow oscillations of the electro-oculogram in Best's macular dystrophy and retinitis pigmentosa.

Authors:  R G Weleber
Journal:  Arch Ophthalmol       Date:  1989-04

5.  Refining the locus for Best vitelliform macular dystrophy and mutation analysis of the candidate gene ROM1.

Authors:  B E Nichols; R Bascom; M Litt; R McInnes; V C Sheffield; E M Stone
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

6.  Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy.

Authors:  K M Bushby; N J Cleghorn; A Curtis; I D Haggerty; L V Nicholson; M A Johnson; J B Harris; S S Bhattacharya
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

7.  Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13.

Authors:  E M Stone; B E Nichols; L M Streb; A E Kimura; V C Sheffield
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

8.  Human CC10, the homologue of rabbit uteroglobin: genomic cloning, chromosomal localization and expression in endometrial cell lines.

Authors:  M Wolf; J Klug; R Hackenberg; M Gessler; K H Grzeschik; M Beato; G Suske
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

9.  Molecular evidence for non-penetrance in Best's disease.

Authors:  B H Weber; D Walker; B Müller
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

10.  Polymorphisms and rare sequence variants at the ROM1 locus.

Authors:  R A Bascom; L Liu; P Humphries; G A Fishman; J C Murray; R R McInnes
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

View more
  3 in total

1.  Still no evidence for heterogeneity in Best's vitelliform macular dystrophy.

Authors:  C Graff; C Wadelius
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

2.  A gene map of the Best's vitelliform macular dystrophy region in chromosome 11q12-q13.1.

Authors:  H Stöhr; A Marquardt; A Rivera; P R Cooper; N J Nowak; T B Shows; D S Gerhard; B H Weber
Journal:  Genome Res       Date:  1998-01       Impact factor: 9.043

Review 3.  [VMD2 and its role in Best's disease and other retinopathies].

Authors:  H Stöhr; V Milenkowic; B H F Weber
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.